Numazu city
Japan
6
2017-04-27
6
2018-12-11
These are the the leading inventors for applications assigned to CanBas Co., Ltd.:
CanBas Co., Ltd. based in Numazu city, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment
#2 | 2008-11-27 ✅ Patent 7,629,364 granted on 2009-12-08Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments
#3 | 2008-11-06 ✅ Patent 8,084,454 granted on 2011-12-27Compounds with anti-cancer activity
#4 | 2008-09-18 ✅ Patent 7,652,042 granted on 2010-01-26Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments
#5 | 2006-06-08 ✅ Patent 7,407,985 granted on 2008-08-05Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments
#6 | 2006-04-20 ✅ Patent 7,476,657 granted on 2009-01-13Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
121393 ⎘